Quantcast

Latest Hurler Syndrome Stories

2010-10-19 07:00:00

NOVATO, Calif., Oct. 19 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia.

2010-10-07 08:00:00

NOVATO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 28, at 5:00 p.m.

2010-10-05 08:00:00

NOVATO, Calif., Oct. 5 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) will host a Research and Development Day for the investment community on Tuesday, October 19, 2010 from 8:00 a.m. to 12:00 p.m. at the St. Regis Hotel in New York City.

2010-09-23 08:00:00

NOVATO, Calif., Sept. 23 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today the appointment of William D. Young and Kenneth M. Bate to its Board of Directors. "We are extremely pleased to welcome William Young and Kenneth Bate to our Board of Directors.

2010-09-14 08:00:00

NOVATO, Calif., Sept. 14 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-09-09 08:00:00

NOVATO, Calif., Sept. 9 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-09-08 08:00:00

NOVATO, Calif., Sept. 8 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Robert W.

2010-09-07 08:00:00

NOVATO, Calif., Sept. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-09-01 08:00:00

NOVATO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-08-30 08:00:00

NOVATO, Calif., Aug. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has received orphan drug designation from the U.S.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related